Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2018-2025

Published On: September 2018 | Report ID: 73981 | Category: Pharmaceuticals and HealthcarePages: 94

This report focuses on the global Companion Diagnostic Tests in Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Tests in Oncology development in United States, Europe and China.

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

In 2017, the global Companion Diagnostic Tests in Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

Abbott

Roche

Genomic Health

QIAGEN

Agilent

Agendia

BioMerieux

Illumina

Siemens Healthcare

Thermo Fisher

Market segment by Type, the product can be split into

Protein Detection

DNA Detection

Market segment by Application, split into

Pharmaceutical & Biotechnology Companies

Medical Device Companies

Research Institutes

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Companion Diagnostic Tests in Oncology status, future forecast, growth opportunity, key market and key players.

To present the Companion Diagnostic Tests in Oncology development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Companion Diagnostic Tests in Oncology are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (2013-2025)

1.4.2 Protein Detection

1.4.3 DNA Detection

1.5 Market by Application

1.5.1 Global Companion Diagnostic Tests in Oncology Market Share by Application (2013-2025)

1.5.2 Pharmaceutical & Biotechnology Companies

1.5.3 Medical Device Companies

1.5.4 Research Institutes

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Companion Diagnostic Tests in Oncology Market Size

2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions

2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2013-2025)

2.2.2 Companion Diagnostic Tests in Oncology Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Companion Diagnostic Tests in Oncology Market Size by Manufacturers

3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2013-2018)

3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)

3.2 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served

3.3 Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service

3.4 Date of Enter into Companion Diagnostic Tests in Oncology Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018)

4.2 Global Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018)

5 United States

5.1 United States Companion Diagnostic Tests in Oncology Market Size (2013-2018)

5.2 Companion Diagnostic Tests in Oncology Key Players in United States

5.3 United States Companion Diagnostic Tests in Oncology Market Size by Type

5.4 United States Companion Diagnostic Tests in Oncology Market Size by Application

6 Europe

6.1 Europe Companion Diagnostic Tests in Oncology Market Size (2013-2018)

6.2 Companion Diagnostic Tests in Oncology Key Players in Europe

6.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type

6.4 Europe Companion Diagnostic Tests in Oncology Market Size by Application

7 China

7.1 China Companion Diagnostic Tests in Oncology Market Size (2013-2018)

7.2 Companion Diagnostic Tests in Oncology Key Players in China

7.3 China Companion Diagnostic Tests in Oncology Market Size by Type

7.4 China Companion Diagnostic Tests in Oncology Market Size by Application

8 Japan

8.1 Japan Companion Diagnostic Tests in Oncology Market Size (2013-2018)

8.2 Companion Diagnostic Tests in Oncology Key Players in Japan

8.3 Japan Companion Diagnostic Tests in Oncology Market Size by Type

8.4 Japan Companion Diagnostic Tests in Oncology Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2013-2018)

9.2 Companion Diagnostic Tests in Oncology Key Players in Southeast Asia

9.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type

9.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application

10 India

10.1 India Companion Diagnostic Tests in Oncology Market Size (2013-2018)

10.2 Companion Diagnostic Tests in Oncology Key Players in India

10.3 India Companion Diagnostic Tests in Oncology Market Size by Type

10.4 India Companion Diagnostic Tests in Oncology Market Size by Application

11 Central & South America

11.1 Central & South America Companion Diagnostic Tests in Oncology Market Size (2013-2018)

11.2 Companion Diagnostic Tests in Oncology Key Players in Central & South America

11.3 Central & South America Companion Diagnostic Tests in Oncology Market Size by Type

11.4 Central & South America Companion Diagnostic Tests in Oncology Market Size by Application

12 International Players Profiles

12.1 Abbott

12.1.1 Abbott Company Details

12.1.2 Company Description and Business Overview

12.1.3 Companion Diagnostic Tests in Oncology Introduction

12.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.1.5 Abbott Recent Development

12.2 Roche

12.2.1 Roche Company Details

12.2.2 Company Description and Business Overview

12.2.3 Companion Diagnostic Tests in Oncology Introduction

12.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.2.5 Roche Recent Development

12.3 Genomic Health

12.3.1 Genomic Health Company Details

12.3.2 Company Description and Business Overview

12.3.3 Companion Diagnostic Tests in Oncology Introduction

12.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.3.5 Genomic Health Recent Development

12.4 QIAGEN

12.4.1 QIAGEN Company Details

12.4.2 Company Description and Business Overview

12.4.3 Companion Diagnostic Tests in Oncology Introduction

12.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.4.5 QIAGEN Recent Development

12.5 Agilent

12.5.1 Agilent Company Details

12.5.2 Company Description and Business Overview

12.5.3 Companion Diagnostic Tests in Oncology Introduction

12.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.5.5 Agilent Recent Development

12.6 Agendia

12.6.1 Agendia Company Details

12.6.2 Company Description and Business Overview

12.6.3 Companion Diagnostic Tests in Oncology Introduction

12.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.6.5 Agendia Recent Development

12.7 BioMerieux

12.7.1 BioMerieux Company Details

12.7.2 Company Description and Business Overview

12.7.3 Companion Diagnostic Tests in Oncology Introduction

12.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.7.5 BioMerieux Recent Development

12.8 Illumina

12.8.1 Illumina Company Details

12.8.2 Company Description and Business Overview

12.8.3 Companion Diagnostic Tests in Oncology Introduction

12.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.8.5 Illumina Recent Development

12.9 Siemens Healthcare

12.9.1 Siemens Healthcare Company Details

12.9.2 Company Description and Business Overview

12.9.3 Companion Diagnostic Tests in Oncology Introduction

12.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.9.5 Siemens Healthcare Recent Development

12.10 Thermo Fisher

12.10.1 Thermo Fisher Company Details

12.10.2 Company Description and Business Overview

12.10.3 Companion Diagnostic Tests in Oncology Introduction

12.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)

12.10.5 Thermo Fisher Recent Development

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@marketresearchplace.com

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.